-
1
-
2by David Feldman, Paola Kruger, Laure Delbecque, Ashley Duenas, Oana Bernard-Poenaru, Séverine Wollenschneider, Nick Hicks, Janine Ann Reed, Ify Sargeant, Chi Pakarinen, Anne-Marie Hamoir, on behalf of Patient Focused Medicines Development Working Groups 1, on behalf of Patient Focused Medicines Development Working Groups 2A, on behalf of Patient Focused Medicines Development Working Groups 2BGet full text
Published 2021-08-01
Article